Detalhe da pesquisa
1.
Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial.
Am Heart J
; 258: 60-68, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36646196
2.
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Cardiovasc Diabetol
; 21(1): 158, 2022 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35996147
3.
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Diabetes Obes Metab
; 24(4): 704-712, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34984808
4.
Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects.
Arterioscler Thromb Vasc Biol
; 41(8): 2330-2341, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34134520
5.
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Eur Heart J
; 42(26): 2565-2573, 2021 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33197271
6.
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial.
Circulation
; 141(23): 1841-1854, 2020 06 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32223318
7.
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI).
Circulation
; 141(14): 1141-1151, 2020 04 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32178526
8.
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.
Circulation
; 140(7): 529-537, 2019 08 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31163978
9.
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
Stroke
; 51(10): 2901-2909, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32951537
10.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet
; 394(10193): 121-130, 2019 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31189511
11.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Lancet
; 394(10193): 131-138, 2019 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31189509
12.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
N Engl J Med
; 377(14): 1319-1330, 2017 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28844192
13.
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Gastroenterology
; 157(2): 403-412.e5, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31054846
14.
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Gastroenterology
; 157(3): 682-691.e2, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31152740
15.
Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
Am Heart J
; 224: 65-76, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32335402
16.
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial.
Cardiovasc Diabetol
; 19(1): 175, 2020 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33046070
17.
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Cardiovasc Diabetol
; 19(1): 199, 2020 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33239067
18.
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry.
Eur Heart J
; 39(9): 750-757a, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29186454
19.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
N Engl J Med
; 373(23): 2247-57, 2015 Dec 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26630143
20.
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.
Diabetes Obes Metab
; 25(4): 1125-1129, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36546588